Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Leukemia 12Lymphoma 2Leukemia, T-Cell 2Leukemia, Biphenotypic, Acute 2Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Glioblastoma 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Peripheral Blood Stem Cell Transplantation 3fludarabine phosphate 2treosulfan 1Whole-Body Irradiation 1Tacrolimus 1Polymerase Chain Reaction 1Mycophenolic Acid 1Methotrexate 1Mercaptopurine 1Immunoenzyme Techniques 1Filgrastim 1Decitabine 1Cytarabine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Bronchoscopy 1Bronchoalveolar Lavage 1Biopsy 1Azacitidine 1Antilymphocyte Serum 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Myelodysplastic-Myeloproliferative Diseases × Mercaptopurine × Clear all
NCT00047268 2013-09-17

Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Unknown
MyeloidOther hematologic neoplasm

Leukemia, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡